Aft Pharmaceuticals (AFP) Short Interest

Aft Pharmaceuticals (ASX:AFP) had 0.00% of shares reported as short positions as of 2 Aug 2021, representing 667 shares. Aft Pharmaceuticals operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Aft Pharmaceuticals logo
AFP

Aft Pharmaceuticals

Pharmaceuticals, Biotechnology & Life Sciences

AFT Pharmaceuticals is a dynamic multinational company that specializes in developing and in-licensing a broad spectrum of pharmaceutical products. They serve multiple distribution channels, including over-the-counter medications, prescription drugs, and hospital treatments. The company's unique value proposition lies in its extensive product portfolio and strategic partnerships, enhancing its market position within the pharmaceutical industry.

Short position

short percentage0.00%
reported shorts667
shares on issue104.679M

Aft Pharmaceuticals (ASX:AFP) has 0.00% of its shares on issue reported as short positions as of 2 Aug 2021, or about 667 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. AFP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

AFP intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required
Short interest history & FAQ

Company

AI-generated research profile of Aft Pharmaceuticals

pharmaceuticals
biotechnology
healthcare
drug development
over-the-counter

About

address

Level 1, Neilson Building, 129 Hurstmere Road, AUCKLAND, ., NEW ZEALAND, .

Connect

More Pharmaceuticals, Biotechnology & Life Sciences Stocks

Other shorted stocks in this sector

Be the first to discuss AFP

Start a research thread or post the first pulse update